Protalix BioTherapeutics, Inc. PLX
2.54 USD +0.03 (+1.20%)
At closeNov 6, 2026, 4:01 PM EST
2.54 0.00 0.00%
After hours · Nov 6, 4:01 PM ET
2.49 Day range 2.59
1.67 52-week range 3.15
- YTD
- +41.11%
- 1 year
- +14.41%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Curis (NASDAQ:CRIS) stock moved upwards by 83.5% to $1.31 during Wednesday's pre-market session. The company's market cap stands at $1.7 million. SCWorx (NASDAQ:WORX) stock increased by…
prnewswire.com Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026 Company to host conference call and webcast at 8:00 a.m. ET CARMIEL, Israel, Nov. 3, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on…
benzinga.com HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Protalix BioTherapeutics (AMEX:PLX) with a Buy and maintains $12 price target.
benzinga.com Protalix BioTherapeutics Q2 EPS $0.05 Misses $0.12 Estimate, Sales $19.896M Beat $12.931M Estimate Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.12 by 58.33 percent. The company reported quarterly sales of…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market session. The market value of their outstanding shares is at $112.9 million. Barinthus Biotherapeutics…
benzinga.com CORRECTION: Protalix BioTherapeutics Q1 EPS $0.22 Beats $0.06 Estimate, Sales $33.750M Beat $11.468M Estimate Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.06 by 266.67 percent. This is a 540 percent increase over losses of…
benzinga.com Transcript: Protalix BioTherapeutics Q1 2026 Earnings Conference Call 
benzinga.com Earnings Scheduled For May 13, 2026 
benzinga.com HC Wainwright & Co. Reiterates Buy on Protalix BioTherapeutics, Maintains $12 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Protalix BioTherapeutics (AMEX:PLX) with a Buy and maintains $12 price target.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com Earnings Scheduled For March 18, 2026
benzinga.com Protalix BioTherapeutics Expects FY26 Total Revenue To Range From ~$78M To $83M Including $25M Milestone Which Protalix Is Entitled To From Chiesi Financial Outlook: Building Durable Growth and Long–Term ValueProtalix enters 2026 with a profitable commercial business through its partnerships and a focused pipeline aligned to areas of high unmet…- benzinga.com Protalix BioTherapeutics Q4 EPS $(0.06) Misses $0.04 Estimate, Sales $9.300M Miss $16.918M Estimate Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.04 by 250 percent. This is a 166.67 percent decrease over earnings…
- benzinga.com The European Commission Approves 2mg/kg Every-4-weeks Dosing Regimen For Chiesi And Protalix Biotherapeutics' Elfabrio (Pegunigalsidase Alfa) For Fabry Disease Patients Who Are Stable With An Enzyme Replacement Therapy European Commission approved dosing regimen reduces the burden for eligible patients, their families, and the broader healthcare system by extending infusion interval frequency from every-two-weeks…
- benzinga.com Chiesi Group's Unit And Protalix BioTherapeutics Say CHMP Of EMA Issues Positive Opinion Recommending Approval Of 2mg/Kg E4W Dosing Regimen For Elfabrio In Fabry Disease Adult Patients Stable With ERT Treatment Committee for Medicinal Products for Human Use (CHMP) issues a positive opinion following re-examination, which will be reviewed by the European Commission (EC), with a decision anticipated by March…
- benzinga.com Protalix Bets on Gout and Rare Kidney Diseases as It Eyes New Drug Launches in 2026 Protalix BioTherapeutics, Inc. (NYSE:PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases with…
benzinga.com Protalix Biotherapeutics Announced A Collaboration With Secarna Pharmaceuticals For The Discovery Of Novel Antisense Oligonucleotide Therapies Against Multiple Targets For Rare Renal Indications, Deal Terms Were Not Disclosed Partnership combines Protalix's rare disease and biologics expertise with Secarna's AI–powered OligoCreator® platform to jointly develop pharmaceutical candidates for rare renal indicationsProtalix…- benzinga.com Earnings Scheduled For November 13, 2025
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Earnings Scheduled For August 14, 2025 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com Earnings Scheduled For May 9, 2025
benzinga.com Earnings Scheduled For March 17, 2025 - benzinga.com Earnings Scheduled For November 14, 2024
- benzinga.com Earnings Scheduled For March 14, 2024 Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
- benzinga.com Earnings Scheduled For November 6, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
- benzinga.com Earnings Scheduled For August 7, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss at $0.44 per share on revenue of $153.69 million.
- benzinga.com Earnings Scheduled For May 4, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.
- benzinga.com Earnings Scheduled For November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
- benzinga.com Earnings Scheduled For August 15, 2022 Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
- benzinga.com Earnings Scheduled For May 16, 2022 Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
- benzinga.com Earnings Scheduled For March 31, 2022 Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.
- benzinga.com Earnings Scheduled For November 15, 2021 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Before 10 a.m. ET on Friday, 29 companies hit new 52-week lows.
benzinga.com Earnings Scheduled For May 14, 2021 Companies Reporting Before The Bell • Sogou (NYSE:SOGO) is projected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its first quarter.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday This morning 533 companies reached new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday On Tuesday, 596 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Monday Monday morning saw 558 companies set new 52-week highs.
- benzinga.com Earnings Scheduled For October 29, 2020 Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings at $0.27 per share on revenue of $4.72 billion.
- benzinga.com Earnings Scheduled For August 10, 2020 Companies Reporting Before The Bell • Acacia Research Inc. (NASDAQ:ACTG) is expected to report quarterly loss at $0.02 per share on revenue of $200.00 thousand.
- benzinga.com 98 Biggest Movers From Friday Gainers Liberty Global plc (NASDAQ: LBTYB) shares climbed 66.7% to close at $32.00 on Friday. Telefonica is seeking to merge its British mobile operator O2 and Liberty's Virgin Media cable network…
- benzinga.com 86 Biggest Movers From Yesterday Gainers SCWorx Corp. (NASDAQ: WORX) shares climbed 424.9% to close at $12.02 on Monday after the company reported a first installment of purchase order for 48 million coronavirus rapid testing units.
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
- benzinga.com 46 Biggest Movers From Yesterday
- benzinga.com Mid-Afternoon Market Update: NASDAQ Turns Negative; Whirlpool Shares Drop After Earnings Miss
- benzinga.com 34 Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com 22 Stocks Moving In Tuesday's Pre-Market Session